A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability

Richard B. Lipton, Aubrey Manack Adams, Dawn C. Buse, Kristina M. Fanning, Michael L. Reed

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Objective: To compare the methods and baseline characteristics of the American Migraine Prevalence and Prevention (AMPP) and Chronic Migraine Epidemiology and Outcomes (CaMEO) studies. Background: The AMPP and CaMEO studies are the largest longitudinal efforts designed to improve our understanding of episodic and chronic migraine in the United States. The studies have complementary strengths and weaknesses. Methods: This analysis compares and contrasts the study methods and participation rates of the AMPP and CaMEO studies. We then compare and contrast baseline results in terms of demographic characteristics, headache features, and disability as measured by the Migraine Disability Assessment Scale (MIDAS) among people with episodic and chronic migraine. Results: AMPP and CaMEO sampled from panels constructed to be representative of the US population. The AMPP Study collected data using a mailed questionnaire while CaMEO relied on a web survey methodology. Response rates were higher in AMPP (64.8%) than in CaMEO (16.5%). Both studies assessed headache features using the American Migraine Study/AMPP diagnostic module. Both identified persons with episodic (

Original languageEnglish (US)
JournalHeadache
DOIs
StateAccepted/In press - 2016

Fingerprint

Migraine Disorders
Headache
Epidemiology
Cross-Sectional Studies
Demography
Outcome Assessment (Health Care)

Keywords

  • Chronic migraine
  • Demographics
  • Epidemiology
  • Episodic migraine
  • Headache-day frequency
  • Headache-related disability

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study : Demographics and Headache-Related Disability. / Lipton, Richard B.; Manack Adams, Aubrey; Buse, Dawn C.; Fanning, Kristina M.; Reed, Michael L.

In: Headache, 2016.

Research output: Contribution to journalArticle

@article{984ec1df26e647a69320557b16893f2e,
title = "A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability",
abstract = "Objective: To compare the methods and baseline characteristics of the American Migraine Prevalence and Prevention (AMPP) and Chronic Migraine Epidemiology and Outcomes (CaMEO) studies. Background: The AMPP and CaMEO studies are the largest longitudinal efforts designed to improve our understanding of episodic and chronic migraine in the United States. The studies have complementary strengths and weaknesses. Methods: This analysis compares and contrasts the study methods and participation rates of the AMPP and CaMEO studies. We then compare and contrast baseline results in terms of demographic characteristics, headache features, and disability as measured by the Migraine Disability Assessment Scale (MIDAS) among people with episodic and chronic migraine. Results: AMPP and CaMEO sampled from panels constructed to be representative of the US population. The AMPP Study collected data using a mailed questionnaire while CaMEO relied on a web survey methodology. Response rates were higher in AMPP (64.8{\%}) than in CaMEO (16.5{\%}). Both studies assessed headache features using the American Migraine Study/AMPP diagnostic module. Both identified persons with episodic (",
keywords = "Chronic migraine, Demographics, Epidemiology, Episodic migraine, Headache-day frequency, Headache-related disability",
author = "Lipton, {Richard B.} and {Manack Adams}, Aubrey and Buse, {Dawn C.} and Fanning, {Kristina M.} and Reed, {Michael L.}",
year = "2016",
doi = "10.1111/head.12878",
language = "English (US)",
journal = "Headache",
issn = "0017-8748",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study

T2 - Demographics and Headache-Related Disability

AU - Lipton, Richard B.

AU - Manack Adams, Aubrey

AU - Buse, Dawn C.

AU - Fanning, Kristina M.

AU - Reed, Michael L.

PY - 2016

Y1 - 2016

N2 - Objective: To compare the methods and baseline characteristics of the American Migraine Prevalence and Prevention (AMPP) and Chronic Migraine Epidemiology and Outcomes (CaMEO) studies. Background: The AMPP and CaMEO studies are the largest longitudinal efforts designed to improve our understanding of episodic and chronic migraine in the United States. The studies have complementary strengths and weaknesses. Methods: This analysis compares and contrasts the study methods and participation rates of the AMPP and CaMEO studies. We then compare and contrast baseline results in terms of demographic characteristics, headache features, and disability as measured by the Migraine Disability Assessment Scale (MIDAS) among people with episodic and chronic migraine. Results: AMPP and CaMEO sampled from panels constructed to be representative of the US population. The AMPP Study collected data using a mailed questionnaire while CaMEO relied on a web survey methodology. Response rates were higher in AMPP (64.8%) than in CaMEO (16.5%). Both studies assessed headache features using the American Migraine Study/AMPP diagnostic module. Both identified persons with episodic (

AB - Objective: To compare the methods and baseline characteristics of the American Migraine Prevalence and Prevention (AMPP) and Chronic Migraine Epidemiology and Outcomes (CaMEO) studies. Background: The AMPP and CaMEO studies are the largest longitudinal efforts designed to improve our understanding of episodic and chronic migraine in the United States. The studies have complementary strengths and weaknesses. Methods: This analysis compares and contrasts the study methods and participation rates of the AMPP and CaMEO studies. We then compare and contrast baseline results in terms of demographic characteristics, headache features, and disability as measured by the Migraine Disability Assessment Scale (MIDAS) among people with episodic and chronic migraine. Results: AMPP and CaMEO sampled from panels constructed to be representative of the US population. The AMPP Study collected data using a mailed questionnaire while CaMEO relied on a web survey methodology. Response rates were higher in AMPP (64.8%) than in CaMEO (16.5%). Both studies assessed headache features using the American Migraine Study/AMPP diagnostic module. Both identified persons with episodic (

KW - Chronic migraine

KW - Demographics

KW - Epidemiology

KW - Episodic migraine

KW - Headache-day frequency

KW - Headache-related disability

UR - http://www.scopus.com/inward/record.url?scp=84978419132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978419132&partnerID=8YFLogxK

U2 - 10.1111/head.12878

DO - 10.1111/head.12878

M3 - Article

C2 - 27349336

AN - SCOPUS:84978419132

JO - Headache

JF - Headache

SN - 0017-8748

ER -